Vanajakshi Paturu, MD
Geriatric Psychiatry · Fair Lawn, NJNPI 1598876369
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Johnson & Johnson at 34.0% of the total. Reporting peaked in 2019 at $414 and has fallen 94.8% since, to $22 in 2025.
Across 74 payments — averaging $13.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$341
- Alkermes, Inc.$287
- Otsuka America Pharmaceutical, Inc.$192
- Teva Pharmaceuticals USA, Inc.$99
- Lundbeck LLC$61
- Indivior Inc.$22
What the payments were for
- Food & beverage$1,003100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 28 | $341 |
| Alkermes, Inc. | 15 | $287 |
| Otsuka America Pharmaceutical, Inc. | 20 | $192 |
| Teva Pharmaceuticals USA, Inc. | 5 | $99 |
| Lundbeck LLC | 5 | $61 |
| Indivior Inc. | 1 | $22 |
How this compares
$1,003 in reported general payments places this provider in the 80th percentile of 26 geriatric psychiatry providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxcarbazepine | 26 | $435 |
| Hydroxyzine Pamoate | 97 | $415 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $387 |
| Gabapentin | 57 | $355 |
| Trazodone Hcl | 136 | $320 |
| Duloxetine Hcl | 47 | $315 |
| Aripiprazole | 16 | $302 |
| Quetiapine Fumarate | 39 | $291 |
| Fluoxetine Hcl | 53 | $229 |
| Olanzapine | 27 | $210 |
| Divalproex Sodium | 20 | $197 |
| Prazosin Hcl | 37 | $181 |
| Fluticasone Propionate | 12 | $180 |
| Pantoprazole Sodium | 40 | $173 |
| Risperidone | 27 | $131 |
Paid to pharmacies, not to this prescriber.
Other geriatric psychiatry in Fair Lawn
- Sailaja ValivetiFair Lawn$250
- Padmavathy KurraFair Lawn$211
- Pritesh ShahWestwood$5K
- Lina ShihabuddinNewark$2K
- Shailaja ShahHillsborough$1K
- Gina WilberHowell$1K
- Sheema ImranPerth Amboy$853
- Syed RazaBrick$843
- Pooja TandonToms River$781
- Ajanta VinekarPlainsboro$631
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.